More than 70% of dementia cases are not diagnosed in time for patients to receive treatment, but new technology is turning ...

Managing dementia in the complex landscape of neurological disorders stands out as a formidable challenge, affecting millions ...

Dr. Mike Roizen is the founder of www.longevityplaybook.com, and Dr. Mehmet Oz is global advisor to www.iHerb.com, the ...

It is very important to create public awareness about Alzheimer rsquo;s disease, educate them to identify the disease in the ...

Scientists at the West Virginia University Rockefeller Neuroscience Institute hope to unlock the true potential of drugs ...

Alzheimer’s disease, a type of dementia that profoundly alters a person ... Medicare is set to expand its coverage of amyloid PET scans for the diagnosis of Alzheimer’s disease beginning ...

Subtle changes in brain activity in the presence of both amyloid-beta and tau proteins may point to Alzheimer's disease, long ...

There is an urgent need to improve access to new innovations in the diagnosis and treatment of Alzheimer's disease. Embracing breakthroughs such as blood-based biomarker testing, has the potential to ...

Japan is the second major market where LLY's Kisunla has been approved. The drug was first approved in the United States in ...

The most impactful gene is the apolipoprotein E-e4 gene (APOE-e4) – people who carry two APOE-e4 copies have 12 times the ...

In addition to Alzheimer's disease, posterior cortical atrophy may occur with Lewy body dementia and some other progressive ... Patients may also have an ophthalmic exam, blood tests, and MRI, PET, or ...

Brain Imaging: Advanced neuroimaging techniques, including Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) scans, play a pivotal role in detecting structural and functional ...